Nature communications · 2025
Serological evidence of clade Ib Mpox transmission by sex workers and within household in South Kivu, DRC.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Masirika Leandre Murhula, Zaeck Luca M, Ndishimye Pacifique, Udahemuka Jean Claude, Otani Saria, Aarestrup Frank M, Schuele Leonard, Verstrepen Babs E, Jones Scott, Otter Ashley, GeurtsvanKessel Corine H, Musabyimana Jean Pierre, Bengehya Mbiribindi Justin, Minega Ndoli Jules, Oude Munnink Bas B, Siangoli Belesi Freddy, Koopmans Marion P G, de Vries Rory D
Аннотация
Understanding secondary attack rates is a key knowledge gap in the ongoing clade Ib mpox virus (MPXV) outbreak in the Democratic Republic of the Congo. Here, we report the first cross-sectional serological study to investigate local MPXV clade Ib transmission in South Kivu, DRC. Seropositivity was defined as a detectable titer in a cell lysate-based screening ELISA and confirmation by virus neutralization test. Sera were collected in November and December 2023 (n = 120), and in May 2024 (n = 48) from professional sex workers (PSW) and visitors of 25 bars with reports of mpox cases. We detected serological evidence for MPXV infection in 18% and 17% of these sera, respectively, indicating that PSW played an important role in MPXV clade Ib transmission in this region. Additionally, sera from 108 direct contacts of mpox cases from 34 households were collected between September 2023 and May 2024. Serological evidence for MPXV infection was found in at least one serum sample in 50% of households, including in nine households with seropositive minors, providing evidence for close-contact household transmission. Serological studies are needed to comprehend the extent and severity of the ongoing MPXV outbreak, and may be used to guide targeted vaccination strategies, particularly for high-risk groups.